What is the significance of my DHEA‑S (dehydroepiandrosterone sulfate) lab result?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DHEA-S Lab Interpretation

DHEA-S is primarily useful for detecting very high levels (>700 μg/dL) that suggest an androgen-secreting tumor, but routine measurement has limited clinical utility in most populations and should not be used as a screening test for adrenal insufficiency or nonclassic congenital adrenal hyperplasia. 1

Clinical Significance by Context

In Hyperandrogenism/Hirsutism Evaluation

  • DHEA-S is elevated in only 16% of women with normal testosterone levels, and mildly elevated DHEA-S with normal free testosterone is unlikely to change management 1

  • The key androgen to measure is testosterone (preferably free or bioavailable testosterone), not DHEA-S 1

  • Critical threshold: DHEA-S >700 μg/dL raises concern for androgen-secreting tumor and warrants imaging 1

  • The height of DHEA-S elevation below this threshold has poor predictive value for specific diagnoses 1

In Adrenal Insufficiency Assessment

DHEA-S should NOT be used as a primary screening test for adrenal insufficiency, despite being uniformly low in treated patients with ACTH deficiency 2, 3

  • While low age- and gender-matched DHEA-S makes ACTH deficiency "extremely unlikely," when DHEA-S is low, further dynamic testing is still necessary 2

  • In younger patients (≤30 years) with pituitary macroadenomas, a z-score below -2.0 has 100% specificity for HPA insufficiency, but diagnostic value decreases significantly in older individuals 3

  • Recent meta-analysis shows: DHEA-S has 70-87% sensitivity and 87% specificity for diagnosing adrenal insufficiency, but this is based on limited heterogeneous evidence 4

In Adrenal Tumor Evaluation

DHEA-S is NOT a reliable predictor of hormonal activity in incidentally discovered adrenal tumors 5

  • In a cohort of 84 patients with adrenal incidentalomas, low DHEA-S had only 60% sensitivity and 75% specificity for detecting hormonal activity in benign cortical adenomas 5

  • DHEA-S measurement may only be valuable after confirming the cortical origin and benign nature of the tumor 5

In PCOS Diagnosis

DHEA-S is one of several androgens that can be measured, but testosterone (particularly free testosterone) remains the primary androgen for diagnosis 6

  • The 2023 International PCOS Guidelines acknowledge ongoing challenges in determining which specific androgen measurements are most accurate 6

Important Caveats

Age and Gender Dependency

  • DHEA-S levels vary dramatically by age and gender, requiring age- and gender-specific reference ranges 7, 3
  • Levels peak around age 25-30 and decline progressively with age 7
  • After age 45, DHEA-S is higher in men than women 7

Assay Limitations

  • Most hospital immunoassays lack adequate sensitivity and specificity for measuring androgens in women 1
  • LC-MS/MS is the reference standard but has limited accessibility 6, 8
  • There is no uniform laboratory standard, leading to wide inter-assay variability 1

When NOT to Order DHEA-S

  • Do not use for screening nonclassic congenital adrenal hyperplasia - measure early-morning follicular-phase 17-hydroxyprogesterone instead in high-risk populations 1
  • Do not rely on it as the sole test for adrenal insufficiency - dynamic testing remains necessary 2, 3
  • Do not use routinely in hirsutism workup when free testosterone is normal 1

Practical Algorithm

Order DHEA-S when:

  1. Evaluating suspected androgen-secreting tumor (looking for levels >700 μg/dL)
  2. As part of comprehensive hyperandrogenism workup in PCOS (but not as primary test)
  3. In younger patients (<30 years) with pituitary macroadenomas as adjunct to HPA axis assessment

Do NOT order DHEA-S as:

  1. Primary screening for adrenal insufficiency
  2. Screening for nonclassic CAH
  3. Sole test for evaluating adrenal incidentalomas
  4. Routine test when free testosterone is already normal in hirsutism evaluation

References

Research

The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function.

The Journal of clinical endocrinology and metabolism, 2003

Research

Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis.

The Journal of clinical endocrinology and metabolism, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.